Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

May 22, 2018
AHA letter to Representatives Crowley and Costello expressing support for  H.R. 5818, the Opioid Workforce Treatment Act of 2018.
May 16, 2018
AHA letter to the Senate expressing support for S. 2847, the Standard Merger and Acquisition Reviews Through Equal Rules Act of 2018, also known as the SMARTER Act. 
May 16, 2018
AHA letter to Representatives Greg Walden, and Frank Pallone expressing support for The Limited Repeal of the IMD Exclusion for Adult Medicaid Beneficiaries with Substance Use Disorder Act. 
May 10, 2018
The American Hospital Association supports H.R. 5645, the Standard Merger and Acquisition Reviews Through Equal Rules Act of 2018, also known as the SMARTER Act.
May 8, 2018
AHA comments on the Senate Health, Education, Labor and Pensions (HELP) Committee’s discussion draft, titled the “Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.”
May 8, 2018
AHA letter to Representative Ron King expressing support for the Rural Emergency Medical Center Act of 2018 (H.R. 5678).
May 4, 2018
The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas.
May 4, 2018
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate